On Apr. 12, 2018, in one liner decision, Federal Circuit affirmed Patent Trial and Appeal Board’s (PTAB) decision in two IPRs finding certain claims unpatentable.
Previously, PTAB in its decision related to IPR2015-01490 & IPR2015-01493 in Dec 2016 & Jan 2017 found claims of US 7,754,702 and US 8,431,549 unpatentable. These patents are related to administration of stable, high doses of iron. US’702 patent (Exp: 02/13/2027) is listed in Orange Book for INJECTAFER®.
Leave a Reply